Kirjoita tähän hakemasi!

Spring 2023 Frontiers of Science Seminars

Spring 2023 Frontiers of Science Seminars

Frontiers of Science is a 25-year-old seminar series arranged by BioCity Turku, where BioCity Turku researchers invite world-leading scientists to present the latest results from their field of research. The seminars are aimed at both researchers and students and students can get ECT:s for participating.

All seminars are held on Thursdays at 12:00 in BioCity Presidentti Auditorium, if not stated otherwise. There is no registration fee and coffee and sandwiches are served at 11:45.

Click here for more information and the latest updates on the programme.

If you are a student and wish to earn credits, please print out the student seminar diary and ask the coordinator to sign it after the seminar.


February 2nd
Prof. Josef Köhrle, Institute of Experimental Endocrinology, Germany
Endocrine disruption of thyroid development and function
Host: Jorma Toppari (

.February 9th
Prof. Rene Bernards, Netherlands Cancer Institute, Netherlands
Unconventional approaches to cancer therapy
Host: Klaus Elenius (

.February 16th
Dr. Simon Yona, Hebrew University, Israel
Human mononuclear phagocyte kinetics in health and disease
host: Alexander Mildner (

.March 16th
Julian Jones, Imperial College London, UK
Making bioglass bounce for cartilage regeneration
host: Leena Hupa (

.April 13th
Prof. Dipanjan Chowdhury, Dana-Farber Cancer Institute, Harvard Medical School, USA
Expanding the scope of DNA repair factors- novel roles and applications
host: Jukka Westermarck (

.April 27th
in Pha1 auditorium, Pharmacity
Prof. Jason Sheltzer
, Yale School of Medicine, USA
Mischaracterized anti-cancer agents and their true targets
Host: Jukka Westermarck (

.May 4th
Prof. Johanna Myllyharju, University of Oulu, Finland
Hypoxia response and collagen synthesis as therapeutic targets
Host: Jyrki Heino (

.May 25th or June 1st
Prof. Pasi Jänne, Dana-Farber Cancer Institute, Harvard Medical School, USA
Challenges in molecularly targeted treatment of lung cancer
Host: Klaus Elenius (

Original image acquired by Sara Hernández Pérez: Actin cytoskeleton (dark magenta) of B lymphocytes activated on an antigen-coated surface, acquired on an Airyscan LSM880 confocal microscope.